Nicholas W. Baxter - 15 May 2025 Form 4 Insider Report for Lexaria Bioscience Corp. (LEXX)

Role
Director
Signature
/Nicholas Baxter/
Issuer symbol
LEXX
Transactions as of
15 May 2025
Net transactions value
$0
Form type
4
Filing time
16 May 2025, 16:40:21 UTC
Previous filing
30 Jul 2024

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Baxter Nicholas W Director 37H KING'S GATE, ABERDEEN, ABERDEENSHIRE, SCOTLAND, UNITED KINGDOM /Nicholas Baxter/ 16 May 2025 0001312326

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding LEXX common shares 11,000 15 May 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LEXX Stock Options Award $0 +11,000 +21% $0.000000 63,000 15 May 2025 Common Shares 11,000 $1.04 Direct
holding LEXX Stock Options 1,500 15 May 2025 Common Shares 1,500 $3.00 Direct
holding LEXX Stock Options 6,500 15 May 2025 Common Shares 5,000 $3.00 Direct
holding LEXX Stock Options 8,400 15 May 2025 Common Shares 1,900 $3.00 Direct
holding LEXX Stock Options 11,800 15 May 2025 Common Shares 3,400 $3.39 Direct
holding LEXX Stock Options 30,000 15 May 2025 Common Shares 18,200 $1.96 Direct
holding LEXX Stock Options 35,000 15 May 2025 Common Shares 5,000 $0.8700 Direct
holding LEXX Stock Options 40,000 15 May 2025 Common Shares 5,000 $2.36 Direct
holding LEXX Stock Options 52,000 15 May 2025 Common Shares 12,000 $3.39 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.